Cims India 2012 Pdf Download
Canumil Flowers
Background: The aim of this study is to assess the availability and rational use of six essential medicines in private retail outlets in Maharashtra state. The study focuses on the range of brands for each medicine, and the availability of these brands in the pharmacies. The medicines were chosen because they are included in the World Health Organization's (WHO) essential medicines list (EML), the Indian national and Maharashtra state medicines list, and are all included in existing Indian public health initiatives and national disease control programmes. Methods: Data was gathered on the availability of the medicines and the range and frequency of brands in 124 private retail pharmacies between January and May 2012. As there is currently no centralised database in India of available pharmaceutical brands, we collected data on the range of products of the 6 essential medicines available in the Indian market by consulting three open access Indian pharmaceutical databases, CIMS India, Medindia, and Medguide, and the commercial database, Pharmatrac; we compared this data with the results of the survey. The six essential medicines used in this study are: artemisinin (malaria), lamivudine (HIV/AIDS), rifampicin (tuberculosis control), oxytocin (reproductive health), fluoxetine (mental health) and metformin (diabetes). Results: The study found that for each of the selected medicines there were multiple approved products listed in Indian databases, 2186 in total. The Pharmatrac database lists only 1359 brands of the selected medicines; 978 (72%) of these had zero sales in 2011-2012. Our survey found very low availability of the brands: 17% Pharmatrac marketed brands (163/978) and 12% of all Pharmatrac brands (163/1359) were available. Metformin was the only medicine with high availability in the study pharmacies at 91%, Rifampacin was the second highest at 64.5%; the other four medicines were available in less than half the pharmacies. A small number of brands were dominating the market. Conclusion: the survey shows that market competition has generated a large number of brands of the six study medicines but this has not translated into sufficient availability of these medicines in the study pharmacies. The data calls for a review of available brands, taking into consideration levels of sale and grounds for approval, and the setting up of a centralised database of registered pharmaceutical products.
You agree to the storage of all personal information, applications, attachments and draft applications within our system. Your personal and application data and any attached text or documentation are retained by Jibe Apply in accordance with our record retention policy and applicable laws.
You agree that all personal information, applications, attachments and draft applications created by you may be used by us for our recruitment purposes, including for automated job matching. It is specifically agreed that we will make use of all personal information, applications, attachments and draft applications for recruitment purposes only and will not make this information available to any third party unconnected with the our recruitment processes.
You agree to the storage of all personal information, applications, attachments and draft applications within our system. Your personal and application data and any attached text or documentation are retained by Sequoia Apply in accordance with our record retention policy and applicable laws.
We store anonymized interaction data in an aggregated form about visitors and their experiences on our site using cookies and tracking mechanisms. We use this data to fix site defects and improve the general user experience.
This site may collect sensitive personal information as a necessary part of a job application. The data is collected to support one or more job applications, or to match you to future job opportunities. This data is stored and retained for a default period of 12 months to support job matching or improve the user experience for additional job applications. The data for each application is transferred to the Applicant Tracking System in order to move the application through the hiring process.
\nYou have the right to view, update, delete, export, or restrict further processing of your job application data. To exercise these rights, you can e-mail us at pri...@icims.com.
\nConversion Tracking
\nWe store anonymized data on redirects to the career site that is used to measure the effectiveness of other vendors in sourcing job candidates.
\n This site retains personally identifiable information, specifically e-mail addresses, as a necessary part of user login. This data is retained for the duration of the user profile lifecycle and enables user authentication.\n
By clicking below, you are also confirming your identity for purposes of the questionnaire. You may not receive assistance, refer to any written material, or use a calculator (or similar device) while completing the questionnaire.
Unless otherwise directed by the Questionnaire Administrator, you are only authorized to take each requested questionnaire once. Failure to comply may result in disqualification. All Kenexa SelectorTM questionnaires are monitored.
b1e95dc632